The Need for Speed in Bioprocessing: Is Continuous the Answer?
Posted on April 21, 2016
By: Daniel G. Bracewell
Department of Biochemical Engineering, University College London, Bernard Katz Building, London WC1H 0AH, UK
d.bracewell@ucl.ac.uk
Summary There is a current predicament within the pharmaceutical industry to rapidly get products to market and fail those not destined for success as soon as possible – there is a need for speed. The pressure comes from a trend of increasing costs per new drug brought to market1. Similar issu...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
automation, biopharmaceutical manufacture, bioprocessing, consistent product quality, Continuous Processing, continuous techniques, Daniel G. Bracewell, Genzyme, high volumetric productivity, low cycle times, M3C, modelling and control, monitoring, precision medicine, reduced capital cost, reduced equipment size, Speed of bioprocessing, steady state operation, streamlined process flow, therapeutic enzymes, University College London
Related Product Videos
FlexAct® BT: Point of use leak test for Flexboy® bags - - Sartorius Stedim Biotech
The crossflow system for process development - Sartorius Stedim Biotech
Cadence™ BioSMB platform - Pall Corporation
Related Products
MerckActiPro™ media and supplements - GE Healthcare Life Sciences
Finesse
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
